source
- Rhythm Pharmaceuticals expands LG Chem obesity drug license, total payout up to $855 millionRhythm Pharmaceuticals and LG Chem have revised their licensing agreement for the oral obesity and hyperphagia drug bivamelagon, increasing the total scheduled payments. The new terms raise the po…
- Scientists question safety and benefits of three-parent IVF as new UK data raise concernsThe mitochondrial replacement technique, often called three‑parent IVF, was hailed after the United Kingdom reported the birth of eight healthy children whose mothers carried disease‑causing mitoch…